Allen Nunnally

No más puestos en curso

Consumer Services

Commercial Services

Health Services

Perfil

Allen Nunnally worked as an Attorney at Wilmer Cutler Pickering Hale & Dorr LLP.
He then served as the Vice President-Business Development at Foundation Medicine, Inc. from 2016 to 2018.
Currently, he is the Chief Business Officer at Voyager Therapeutics, Inc. since 2019.
Mr. Nunnally completed his undergraduate and graduate degrees at Amherst College.
He also obtained a graduate degree from Boston University School of Law.

Antiguos cargos conocidos de Allen Nunnally.

Empresas	Cargo	Fin
VOYAGER THERAPEUTICS, INC.	Corporate Officer/Principal	08/01/2023
FOUNDATION MEDICINE INC	Corporate Officer/Principal	01/06/2018
Wilmer Cutler Pickering Hale & Dorr LLP Wilmer Cutler Pickering Hale & Dorr LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services	Corporate Officer/Principal	-

Ver el detalle de la experiencia de Allen Nunnally.

Formación de Allen Nunnally.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Allen Nunnally.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	5
Wilmer Cutler Pickering Hale & Dorr LLP Wilmer Cutler Pickering Hale & Dorr LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services	Commercial Services
Amherst College Amherst College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Foundation Medicine, Inc. Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic solutions for cancer care	Health Services
Boston University School of Law Boston University School of Law Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Voyager Therapeutics, Inc. Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system	Health Technology